Tizona Therapeutics

Developer of antibodies to modulate the activity of immunosuppressive cells in the tumor microenvironment

placeSan Francisco, California, United States calendar_todayFounded 2015 groups43 employees language tizonatx.com

Registered entities

Social engagement

Social engagement: 5K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include AbbVie, Abingworth, Canaan, Astellas Venture Management.

Investor typeCountShare
Venture capital667%
Accelerator & incubator111%
Other / undisclosed222%

Recent activity

7 Nov 2025
Event
SITC25
Coming soon